Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Assets: 2022-2025

Historic Assets for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $396.4 million.

  • Praxis Precision Medicines' Assets fell 4.77% to $396.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $396.4 million, marking a year-over-year decrease of 4.77%. This contributed to the annual value of $483.1 million for FY2024, which is 449.31% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' Assets stood at $396.4 million, which was down 12.46% from $452.8 million recorded in Q2 2025.
  • Over the past 5 years, Praxis Precision Medicines' Assets peaked at $483.1 million during Q4 2024, and registered a low of $87.9 million during Q4 2023.
  • Its 3-year average for Assets is $304.1 million, with a median of $396.4 million in 2025.
  • Its Assets has fluctuated over the past 5 years, first slumped by 58.92% in 2023, then soared by 449.31% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Assets (Quarterly) stood at $115.1 million in 2022, then dropped by 23.61% to $87.9 million in 2023, then skyrocketed by 449.31% to $483.1 million in 2024, then decreased by 4.77% to $396.4 million in 2025.
  • Its Assets stands at $396.4 million for Q3 2025, versus $452.8 million for Q2 2025 and $478.7 million for Q1 2025.